10,820 Shares in Aflac Incorporated $AFL Purchased by Commonwealth Retirement Investments LLC

Commonwealth Retirement Investments LLC acquired a new position in Aflac Incorporated (NYSE:AFL) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 10,820 shares of the financial services provider’s stock, valued at approximately $1,141,000.

Other institutional investors also recently bought and sold shares of the company. Mid American Wealth Advisory Group Inc. acquired a new stake in Aflac in the 2nd quarter worth about $26,000. Chilton Capital Management LLC acquired a new position in Aflac during the second quarter worth about $26,000. Whipplewood Advisors LLC boosted its position in Aflac by 1,526.7% during the second quarter. Whipplewood Advisors LLC now owns 244 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 229 shares during the last quarter. AlphaCore Capital LLC acquired a new position in Aflac during the first quarter worth about $28,000. Finally, Hilltop National Bank acquired a new position in Aflac during the second quarter worth about $32,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Stock Up 1.6%

AFL stock opened at $108.73 on Wednesday. The firm has a market cap of $58.15 billion, a PE ratio of 24.66, a PEG ratio of 2.93 and a beta of 0.86. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.11 and a current ratio of 0.11. The firm’s 50 day moving average price is $108.61 and its 200-day moving average price is $105.59. Aflac Incorporated has a one year low of $96.95 and a one year high of $115.43.

Aflac (NYSE:AFL) last released its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 EPS for the quarter. The firm had revenue of $5.91 billion for the quarter. Aflac had a net margin of 15.32% and a return on equity of 15.08%. On average, equities research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac declared that its Board of Directors has approved a stock repurchase program on Tuesday, August 12th that authorizes the company to repurchase 100,000,000 outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Wednesday, November 19th will be issued a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Wednesday, November 19th. Aflac’s dividend payout ratio is currently 52.61%.

Insider Activity at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $102.57, for a total value of $102,570.00. Following the transaction, the director directly owned 25,105 shares in the company, valued at approximately $2,575,019.85. This represents a 3.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. Keefe, Bruyette & Woods boosted their price target on shares of Aflac from $108.00 to $110.00 and gave the stock a “market perform” rating in a research report on Thursday, October 9th. Weiss Ratings restated a “buy (b-)” rating on shares of Aflac in a research report on Wednesday, October 8th. Piper Sandler set a $125.00 price target on shares of Aflac and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Aflac from $96.00 to $100.00 and gave the company a “neutral” rating in a report on Tuesday, July 8th. Three analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Aflac currently has a consensus rating of “Hold” and an average price target of $109.90.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.